This study aimed to investigate the effect of smaller amounts of weight loss in different ways (surgery and diet plus exercise) on intensity, duration and frequency of migraine headaches in obese patients. Of people with migraine and overweight or obese referred to Sina hospital (Hasan Abad Avenue, TUMS, Tehran, Iran) weight loss clinic, 54 patients will be included in this clinical trial study. The characteristics of headache in 54 patients (27 in each of the bariateric surgery group or diet therapy and exercise group) with migraine and morbid obesity (BMI 35 to 93.9 range with co-morbidities or BMI> =40) for 4 weeks before surgery and at the end of the first, and sixth month of the intervention will be examined by trained physicians. In addition, a headache diary form will be fulfilled by the subjects for 4 weeks prospectively. Also, details of diet and exercise after surgery will be obtained using 3 days dietary recall and International Physical Activity Questionnaires (IPAQ) at baseline and at the end of the first and sixth months after beginning the intervention. The treatment procedure will be started after 4 weeks of baseline examination. Inclusion criteria for patients in the study were as follows having more than 15 headache days per month for at least 3 months; avoiding the use of migraine prophylactic drugs in the last 4 weeks; lack of advanced disease including kidney, heart and liver disease; the absence of major depression and psychotic disorders; suffering from morbid obesity (BMI 35 range to 39/9 with co-morbidities or BMI> =40). The exclusion criteria were as follows: lack of adherence to diet and exercise to more than 70%; pregnancy; unwillingness to cooperate in the study. The main objectives of this trial: the effect of weight loss through bariatric surgery on severity of migraine headache(using VAS), frequency and duration of migraine at one, and six months after the intervention. The effect of weight loss through diet therapy and exercise on severity of migraine headache(using VAS), frequency and duration of migraine at one, and six months after the intervention.